[Federal Register Volume 82, Number 211 (Thursday, November 2, 2017)]
[Notices]
[Pages 50887-50888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23863]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S.

FOR FURTHER INFORMATION CONTACT: Licensing information and copies of 
the patent applications listed below may be obtained by emailing the 
indicated licensing contact Michael Shmilovich, <a href="/cdn-cgi/l/email-protection#cdbea5a0a4a1a2bba08da3a4a5e3aaa2bb"><span class="__cf_email__" data-cfemail="b4c7dcd9ddd8dbc2d9f4dadddc9ad3dbc2">[email protected]</span></a> at the 
National Heart, Lung, and Blood, Office of Technology Transfer and 
Development Office of Technology Transfer, 31 Center Drive Room 4A29, 
MSC2479, Bethesda, MD 20892-2479; telephone: 301-402-5579. A signed 
Confidential Disclosure Agreement may be required to receive copies of 
the patent applications.

SUPPLEMENTARY INFORMATION: This notice is in accordance with 35 U.S.C. 
209 and 37 CFR 404 to achieve commercialization of results of 
federally-funded research and development. Foreign patent applications 
are filed on selected inventions to extend market coverage for 
companies and may also be available for licensing. A description of the 
technology follows.

Endo-Cameral Closure Device

    Description of Technology: Devices and methods for closing a hole 
in the wall of a cardiovascular structure from the inside using a self-
assembling closure device. The closure device can be delivered to the 
subject hole from the inside of the cardiovascular chamber using a 
transcatheter approach. The methods are techniques involve deploying 
the closure device from the delivery device such that an endo-cameral 
portion of the closure device self-expands first to cover the hole from 
the inside, and then extra-cameral arms of the device are released to 
self-deploy against the outside of the wall by

[[Page 50888]]

withdrawal of a retaining element, such as a guidewire, to secure the 
closure device to the wall.
    Potential Commercial Applications: Endovascular interventions.
    Inventors: Toby Rogers, Merdim Sonmez, Robert Lederman, Ozgur 
Kocaturk, (NHLBI).
    Intellectual Property: HHS Reference No. E-273-2015/0, U.S. 
Provisional Patent Application 62/236,734 filed October 2, 2015, 
International Patent Application PCT/US2016/054961 filed September 30, 
2016.
    Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019; 
<a href="/cdn-cgi/l/email-protection#24574c494d484b5249644a4d4c0a434b52"><span class="__cf_email__" data-cfemail="d9aab1b4b0b5b6afb499b7b0b1f7beb6af">[email protected]</span></a>.

    Dated: October 23, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood 
Institute, Office of Technology Transfer and Development.
[FR Doc. 2017-23863 Filed 11-1-17; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>